Camtek drops 15% after Q1 profit decline tempers upbeat revenue outlook

Camtek Ltd. (CAMT) is down 15.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to Camtek’s first-quarter 2026 results, where revenue grew modestly but profitability declined year over year. Even with a higher Q2 revenue outlook, investors may be focusing on margin/operating-income pressure and the idea that strong demand expectations were already priced in.

Details:

Camtek reported Q1 2026 revenue of $121.7 million, up about 2.5% versus Q1 2025.

GAAP operating income fell to $27.3 million (about a 22.4% operating margin), down roughly 17% year over year.

GAAP net income was $31.6 million, or $0.63 per diluted share, down from $0.70 per diluted share in the prior-year quarter.

For Q2 2026, the company guided revenue to $129 million to $131 million and reiterated expectations for a stronger second half versus the first half of 2026.

Sources:

PR Newswire, SEC (Form 6-K), Associated Press

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CAMT Hedge Fund Activity

We have seen 109 institutional investors add shares of $CAMT stock to their portfolio, and 86 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. added 636,773 shares (+38.2%) to their portfolio in Q1 2026, for an estimated $96,541,154
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 543,248 shares (+inf%) to their portfolio in Q4 2025, for an estimated $57,771,708
WASATCH ADVISORS LP removed 439,679 shares (-13.9%) from their portfolio in Q1 2026, for an estimated $66,659,733
FMR LLC added 333,375 shares (+36.2%) to their portfolio in Q4 2025, for an estimated $35,452,764
INVESCO LTD. removed 231,797 shares (-99.1%) from their portfolio in Q4 2025, for an estimated $24,650,451
BANK OF AMERICA CORP /DE/ added 147,352 shares (+199.0%) to their portfolio in Q4 2025, for an estimated $15,670,148
MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. added 140,796 shares (+12.0%) to their portfolio in Q4 2025, for an estimated $14,972,950

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CAMT Analyst Ratings

Wall Street analysts have issued reports on $CAMT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 02/19/2026

To track analyst ratings and price targets for $CAMT, check out Quiver Quantitative's $CAMT forecast page.

$CAMT Price Targets

Multiple analysts have issued price targets for $CAMT recently. We have seen 10 analysts offer price targets for $CAMT in the last 6 months, with a median target of $175.0.

Here are some recent targets:

Brian Chin from Stifel set a target price of $185.0 on 04/17/2026
Shane Brett from Morgan Stanley set a target price of $161.0 on 03/24/2026
Charles Shi from Needham set a target price of $175.0 on 02/19/2026
Tom O'Malley from Barclays set a target price of $175.0 on 02/19/2026
Edward Yang from Oppenheimer set a target price of $180.0 on 02/19/2026
Mark Lipacis from Evercore ISI Group set a target price of $190.0 on 02/18/2026
Craig Ellis from B. Riley Securities set a target price of $175.0 on 01/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.